Skip to content

Clinical trials

Phase 1 trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Country / region: Israel Clear all

471 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20043
200510
200620
200715
20088
200920
201024
201127
201217
201323
201418
201515
201615
201724
201816
201919
202026
202132
202237
202331
202429
202522
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed192
Unknown status97
Terminated59
Recruiting50
Active, not recruiting44
Withdrawn21
Suspended4
Enrolling by invitation2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization42
AbbVie37
Novartis Pharmaceuticals26
Merck Sharp & Dohme LLC20
Janssen Research & Development, LLC19
Sheba Medical Center17
Hoffmann-La Roche12
Assaf-Harofeh Medical Center10
Tel-Aviv Sourasky Medical Center10
Shalvata Mental Health Center8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms60
Carcinoma, Non-Small-Cell Lung32
Multiple Myeloma24
Lymphoma, Non-Hodgkin18
Melanoma16
Neoplasm Metastasis16
Colorectal Neoplasms15
Leukemia, Lymphocytic, Chronic, B-Cell15
Triple Negative Breast Neoplasms14
Squamous Cell Carcinoma of Head and Neck13

Trials

Showing 26 to 50 of 471. Each trial links to its page on Pharma Observatory.

371 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.